Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

TG Therapeutics, Inc. - Common Stock (NQ: TGTX )

37.06 -0.17 (-0.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TG Therapeutics, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
What's Going On With TG Therapeutics Stock Today?
TG Therapeutics Inc (NASDAQ: TGTX) shares are down over 40%. 
Via Benzinga
Sales Of TG Therapeutics' New Product Doubled — Here's Why Shares Halved
TG Therapeutics reported light Briumvi sales and a new deal for its highly anticipated drug. 
Via Investor's Business Daily
Why TG Therapeutics Stock Is Crashing Today
The drugmaker delivered a couple of surprises in Q2. 
Via The Motley Fool
US Stocks Mixed; Pfizer Earnings Beat Views
U.S. stocks were mixed this morning, with the Dow Jones trading slightly higher on Tuesday. Following the market opening Tuesday, the Dow traded up 0.03% to 35,568.68 while the NASDAQ fell 0.57% to... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Analyst Ratings for TG Therapeutics
Via Benzinga
What's Going On With TG Therapeutics (TGTX) Stock?
TG Therapeutics, Inc. (NASDAQ: TGTX) shares are moving higher on Friday. What To Know: 
Via Benzinga
Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg
The companies are rivals in the multiple sclerosis treatment realm with Ocrevus and Briumvi. 
Via Investor's Business Daily
Why iMedia Brands Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Prestige Wealth Inc. (NASDAQ: PWM) shares jumped 65.6% to $8.28. Prestige Wealth reported pricing of $5 million initial public offering of 1 million shares of common stock at a price of $5 per... 
Via Benzinga
Analyst Expectations for TG Therapeutics's Future
Via Benzinga
Where TG Therapeutics Stands With Analysts
Via Benzinga
Alibaba, Kura Sushi USA And Other Big Stocks Moving Higher On Friday
U.S. stocks traded mixed, with the Dow Jones dropping around 30 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Apellis Pharmaceuticals, TG Therapeutics, and Viking Therapeutics Were on the Move Today
These three biotech stocks were on the volatile side today. 
Via The Motley Fool
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
The major indexes retreated for most of the week on banking fears, 
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Top 1% Biotech TG Therapeutics Obliterates Bullish Sales Calls — And Rockets
The company makes a one-hour, twice-a-year infusion for multiple sclerosis. 
Via Investor's Business Daily
IVERIC bio, Ascendis Pharma And Other Big Stocks Moving Higher In Monday's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording gains in today’s pre-market trading session. Apollomics, Inc. (NASDAQ: APLM) surged 58.4% to $7.35 in pre-market trading... 
Via Benzinga
Here Are The Best-Performing Industry ETFs And Major Stock Contributors In April
It's a good time to look at how the major U.S. stock industry ETFs performed this month, as April comes to an end. In April, we saw the broader U.S. 
Via Benzinga
3 Top Biotech Stocks Defying the Bear Market
All three companies have therapies with strong sales potential. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Stock Market Rally Mixed Amid Recession Worries; JPMorgan Headlines Earnings: Weekly Review
The Nasdaq was flat while the Dow rose amid rising recession fears. 
Via Investor's Business Daily
Get In Now. 7 Stocks That Are Set to Soar.
While it’s always difficult to determine which stocks to buy might break out imminently, speculators should watch these ideas. 
Via InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why Shares of TG Therapeutics Soared on Tuesday
Early reports of strong sales for its recently approved multiple sclerosis drug gave the stock a jolt. 
Via The Motley Fool
Wall Street Struggles For Direction As Oil Inches Higher
Stocks are mixed, as investors look ahead to this week's economic data. 
Via Talk Markets
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.